WallStreetZenWallStreetZen

NASDAQ: MIST
Milestone Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MIST past revenue growth

How has MIST's revenue growth performed historically?
Company
-80%
Industry
151.46%
Market
17.61%
MIST's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MIST's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

MIST earnings and revenue history

Current Revenue
$1.0M
Current Earnings
-$59.7M
Current Profit Margin
-5,968.5%

MIST Return on Equity

Current Company
-171%
Current Industry
-63.5%
Current Market
188%
MIST's Return on Equity (-171%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MIST announces earnings.

MIST Return on Assets

Current Company
-64.4%
Current Industry
2.9%
MIST is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MIST Return on Capital Employed

Current Company
-84.02%
Current Industry
19.5%
MIST's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MIST vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MIST$1.00M-$57.04M-$59.69M-74.18%N/A
SGMO$176.23M-$240.71M-$257.83M+15.85%N/A
SLS$0.00-$36.85M-$37.34M-100.00%N/A
ALVR$0.00-$182.25M-$190.42M-100.00%N/A
MCRB$126.33M-$85.43M-$113.72M+34.91%N/A
View Top Biotech Stocks

MIST earnings dates

Next earnings date
May 9, 2024

Milestone Pharmaceuticals Earnings & Revenue FAQ

What were MIST's earnings last quarter?

On Invalid Date, Milestone Pharmaceuticals (NASDAQ: MIST) reported Q4 2023 earnings per share (EPS) of -$0.32, up 3.23% year over year. Total Milestone Pharmaceuticals earnings for the quarter were -$13.61 million. In the same quarter last year, Milestone Pharmaceuticals's earnings per share (EPS) was -$0.31.

If you're new to stock investing, here's how to buy Milestone Pharmaceuticals stock.

What was MIST's earnings growth in the past year?

As of Q2 2024, Milestone Pharmaceuticals's earnings has grown year over year. Milestone Pharmaceuticals's earnings in the past year totalled -$59.69 million.

What is MIST's earnings date?

Milestone Pharmaceuticals's earnings date is Invalid Date. Add MIST to your watchlist to be reminded of MIST's next earnings announcement.

What was MIST's revenue last quarter?

On Invalid Date, Milestone Pharmaceuticals (NASDAQ: MIST) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Milestone Pharmaceuticals's revenue was $3.50 million.

What was MIST's revenue growth in the past year?

As of Q2 2024, Milestone Pharmaceuticals's revenue has grown -80% year over year. This is 231.46 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Milestone Pharmaceuticals's revenue in the past year totalled $1.00 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.